Effect of mycophenolate mofetil (MMF) on systemic sclerosis-related interstitial lung disease with mildly impaired lung function: a double-blind, placebo-controlled, randomized trial

Standardisation of spirometry

Martin R. Miller, J. Hankinson, Vito Brusasco et al. · European Respiratory Journal · 2005 · 15.7K citations · Full text

Computing, Biomedical Informatics, Health Informatics +17

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

F.H.J. van den Hoogen, Dinesh Khanna, Jaap Fransen et al. · Annals of the Rheumatic Diseases · 2013 · 2.9K citations

Medicine, Clinical Sciences, Internal Medicine +15

Standardisation of the single-breath determination of carbon monoxide uptake in the lung

Neil R. MacIntyre, R. O. Crapo, Giovanni Viegi et al. · European Respiratory Journal · 2005 · 2.3K citations · Full text

Medicine, Internal Medicine, Physiology +8

Cyclophosphamide versus Placebo in Scleroderma Lung Disease

Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements et al. · New England Journal of Medicine · 2006 · 1.7K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

A. J. Tyndall, Bettina Bannert, Paolo Airó et al. · Annals of the Rheumatic Diseases · 2010 · 1.4K citations · Full text

Public Health, Biostatistics, Cardiology +14